The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Mercia Fund Management AGM

21 Jan 2016 07:00

RNS Number : 5108M
Mercia Technologies PLC
21 January 2016
 

RNS Reach

 

21 January 2016

Mercia Technologies PLC

 

Notice of Mercia Fund Management AGM

 

Mercia Technologies PLC (AIM: MERC, "Mercia"), a Midlands-based investment group building, funding and commercialising technology businesses in the UK, announces that Mercia Fund Management Ltd ("MFM"), its wholly-owned subsidiary and a regulated fund management company, will hold its Annual General Meeting in respect of its third party funds under management at 5.30pm today, 21 January 2016, at the Ramada Warwick Hotel & Conference Centre, Kenilworth, CV8 2LN.

 

MFM manages seven funds with a total of circa £28m under management, through which Mercia has access over time to a portfolio of potential emerging stars for its direct investment activity. Ian Livingstone, Founder of the Games Workshop franchise, will be the guest speaker, and three portfolio companies - Aston Eyetech, Edge Case Games and Intelligent Health - will be presenting at the AGM. Mercia holds a direct investment in Edge Case Games.

 

The company presentations will be available on Mercia's website (www.merciatechnologies.com).

 

This event brings our existing private and public investors together with our advisers, university partners and portfolio companies across the Mercia group. There will be no material information presented that is not already in the public domain.

 

For further information contact:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu / Mark Connelly (NOMAD)

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Lauren Foster

 

 

Note to editors

Mercia creates, funds and develops technology businesses nationally with an emphasis on the Midlands, the North of England and Scotland. The Group facilitates technology transfer, company formation, incubation, commercialisation and investment, with approximately 50% of its investments being university spinouts. Mercia invests across technology sectors in which it has deep sector expertise.

 

The Mercia model is one of patiently nurturing businesses via its third party funds under management and then scaling them with direct investments at the point of commercial traction. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADBLFLQFFZBBD
Date   Source Headline
7th Jul 202211:51 amRNSDirector/PDMR Dealings
5th Jul 20227:00 amRNSPreliminary Results
27th Jun 20227:00 amRNSInvestor Presentation
23rd May 20227:00 amRNSNotice of Results
16th May 20227:00 amRNSPublication of ‘The Insight’ Newsletter
12th May 20227:00 amRNSMercia's EIS Funds raise c.£20million
26th Apr 202210:27 amRNSTR-1: Notification of major holdings
11th Apr 20227:00 amRNSUpdate on proceeds from sale of Faradion
1st Apr 202211:10 amRNSTR-1: Notification of major holdings
29th Mar 20227:00 amRNSnDreams receives significant new investment
10th Mar 20227:06 amRNSMercia’s Northern VCTs raise £40.0million
28th Feb 20227:00 amRNSFurther direct investment into MIP Diagnostics
18th Feb 20229:49 amRNSTR-1: Notification of major holdings
5th Jan 202212:36 pmRNSDirector/PDMR Dealings
5th Jan 20227:00 amRNSCompletion of the sale of Faradion
31st Dec 20217:00 amRNSSale of Faradion Limited
22nd Dec 20217:00 amRNSFurther direct investment into Intechnica Group
7th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSSoccer Manager secures significant new licences
25th Nov 20217:00 amRNSNVT performance fee entitlement and trading update
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.